Sign in →

Test Code PDR Post Delivery Rhogam (Fetal Screen)

Synonyms

  • Rosette test
  • FMH Screen

Clinical Significance

The use of a test to detect large fetal-maternal hemorrhages is required in AABB standards for blood banks and transfusion services.

Methodology

A suspension of red blood cells from the D-Negative mother is mixed with reagent containing anti-D and is incubated for 5 minutes at room temperature. During incubation any minor population of D-positive cells are coated with anti-D. After incubation cells are washed to remove all unbound antibody and indicator cells are added. One antigen-binding site free to attach to an Rh antigen of the indicator cells. the red cell mixture is centrifuged and examined microscopically for mixed-field agglutination in the form of rosettes at low power. The indicator cells added after washing form rosettes around the individual cells leading to larger agglutinates for detection.

Sample Type

Preferred Sample Type
Lavender top - Packed RBCs

Centrifuge: Yes (In Blood Bank)

Specimen Stability

Temperature Time
Refrigerated (1-10°C) (store) 48 hours

 

Specimen Minimum Volume

0.5 mL

Result Reporting

Normal
Negative

 

Abnormal
Positive*

*Positive fetal screens reflex to a Kleihauer Betke

Rejection Criteria

  • Samples not properly labeled (2 patient identifiers required)
  • Grossly hemolyzed specimens

Availability

Performed STAT
24/7 Yes

 

Performing Laboratory

MultiCare Yakima Memorial Hospital Laboratory

Lab Department

Blood Bank

CPT Code

85461

LOINC

33900-2 Fetal cell screen Rosette test QI (Bld)

Related Tests